Press release
End Stage Renal Disease (ESRD) Drug Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends
End Stage Renal Disease (ESRD) Drug Market
The upswing in obesity and diabetes incidences is anticipated to boost the expansion of the end-stage renal disease (ESRD) drug market. Obesity is characterized by abnormal or excess adipose tissue accumulation that risks health, whereas diabetes is a persistent ailment that occurs when the pancreas fails to produce sufficient insulin or the body can't effectively use the insulin it produces. In the case of renal disease patients, controlling fluid and electrolyte balance, blood pressure, and the elimination of waste through dialysis can enhance overall health, potentially leading to weight loss and improved blood sugar stability. For instance, as stated by the World Obesity, a national and regional association network based in the US dedicated to obesity research and management, in March 2022, the obesity population is projected to increase to 892 million by 2025 and further to 1,025 million by 2030. Moreover, the National Health Service, a publicly funded healthcare system based in the UK, estimated in February 2023 that by 2030, the number of diabetes patients in the UK could surge to 5.5 million, affecting nearly 9% of the population. Hence, the escalating incidences of obesity and diabetes are predicted to stimulate the ESRD drug market.
Get Your End Stage Renal Disease (ESRD) Drug Market Report Here:
https://www.thebusinessresearchcompany.com/report/end-stage-renal-disease-esrd-drug-global-market-report
What is the future CAGR of the end stage renal disease (esrd) drug market, and how will it impact industry expansion?
The drug market for end stage renal disease (ESRD) has been experiencing swift growth in the last few years. The market size is predicted to expand from $131.41 billion in 2024 to an impressive $149.88 billion by 2025, projecting an annual growth rate (CAGR) of 14.1%. Factors contributing to historical growth include a rising number of ESRD cases, an aging population, increased access to healthcare services, supportive government initiatives and policies, and a growing acceptance of renal replacement therapies.
Anticipated to witness accelerated growth over the coming years, the market size of the end stage renal disease (ESRD) drug is projected to reach $268.44 billion in 2029, visualizing a compound annual growth rate (CAGR) of 15.7%. This growth expected in the forecasted timeframe can be credited to the advent of newer therapeutic strategies and drug advancements, increased health care expenditures, the mounting global load of chronic kidney diseases, bespoke medicinal approaches, regulatory endorsements, and expedited sanctioning processes. The key trends during the projected timeline are likely to include an escalated occurrence of end stage renal disease, progress in therapeutic modalities, amplified focus on precision medicine, inclination towards combination therapies, and the incorporation of technology in healthcare.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9437&type=smp
What are the most significant trends transforming the end stage renal disease (esrd) drug market today?
A significant trend that is intensifying in the end-stage renal disease (ESRD) drug market is product innovation. To stay competitive in the market, major corporations involved in the ESRD drug market are prioritizing the development of ground-breaking solutions. In a notable instance from April 2022, UK-based pharmaceutical and biotech company GlaxoSmithKline PLC shared that its New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), was given the green light by the US Food and Drug Administration (FDA). This was targeted at potentially treating patients with chronic kidney disease anemia (CKD). This advanced product leverages unique, Nobel-prize winning science that unravels how cells detect and adapt to the presence of oxygen.
Which key market segments comprise the end stage renal disease (esrd) drug market and drive its revenue growth?
The end stage renal disease (ESRD) drug market covered in this report is segmented -
1) By Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products
2) By Indication: End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkaliemia
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Calcimimetics: Cinacalcet, Etelcalcetide
2) By Vitamin D: Calcitriol, Doxercalciferol, Paricalcitol
3) By Sterols: Ergocalciferol, Cholecalciferol
4) By Potassium Binders: Sodium Polystyrene Sulfonate, Patiromer, Sodium Zirconium Cyclosilicate
5) By Calcium-Based Phosphate Binders: Calcium Acetate, Calcium Carbonate
6) By Other Products: Iron Supplements, Erythropoiesis-Stimulating Agents
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9437
What regions are at the forefront of end stage renal disease (esrd) drug market expansion?
North America was the largest region in the end stage renal disease (ESRD) drug market in 2024. The regions covered in the end stage renal disease (ESRD) drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the leading players fueling growth in the end stage renal disease (esrd) drug market?
Major companies operating in the end stage renal disease (ESRD) drug market include Pfizer Inc., AstraZeneca plc, Sanofi SA, Astellas Pharma Inc., Novartis AG, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd., Kissei Pharmaceutical Co. Ltd., Baxter International Inc., AbbVie Inc., Amgen Inc., Akebia Drugs Inc., Bayer AG, Bristol-Myers Squibb Company, B. Braun SE, Asahi Kasei Medical Co. Ltd., Nikkiso Co. Ltd., Abbott Laboratories, Merck Co. & KGaA
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9437&type=smp
What Is Covered In The End Stage Renal Disease (ESRD) Drug Global Market Report?
• Market Size Forecast: Examine the end stage renal disease (esrd) drug market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the end stage renal disease (esrd) drug market for a structured understanding.
• Key Players Overview: Analyze major players in the end stage renal disease (esrd) drug market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the end stage renal disease (esrd) drug market.
• Segment Contributions: Evaluate how different segments drive overall growth in the end stage renal disease (esrd) drug market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the end stage renal disease (esrd) drug market.
• Industry Challenges: Identify potential risks and obstacles affecting the end stage renal disease (esrd) drug market.
• Competitive Landscape: Review strategic developments in the end stage renal disease (esrd) drug market, including expansions, agreements, and new product launches.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release End Stage Renal Disease (ESRD) Drug Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here
News-ID: 3892034 • Views: …
More Releases from The Business Research Company
2025-2034 Inkjet Coder Market Evolution: Disruptions, Innovations, and Untapped …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Inkjet Coder Market Through 2025?
Strong growth has been witnessed in recent years in the inkjet coder market. It is projected that this market will expand from $2.11 billion in 2024 to $2.27 billion in 2025, experiencing a compound annual growth rate…
Global Industrial Cooking Fire Protection Systems For Food Manufacturing Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Industrial Cooking Fire Protection Systems For Food Manufacturing Industry Market Size Be by 2025?
Over the past few years, the market size for industrial cooking fire protection systems used in food manufacturing has seen a consistent growth. It is projected that the market value will grow…
High Speed Engine Market Trends That Will Shape the Next Decade: Insights from I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the High Speed Engine Market Size By 2025?
The market for high speed engines has seen considerable growth in the last few years. The market which is valued at $24.17 billion in 2024 is predicted to reach $25.58 billion in 2025, experiencing a Compound Annual Growth…
Industrial Sector Growth Fuels Expansion Of Evaporative Cooling Market: The Driv …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Evaporative Cooling Market Size Growth Forecast: What to Expect by 2025?
The market size for evaporative cooling has seen a robust growth in recent times. The outlook predicts an escalation from $6.41 billion in 2024 to $6.8 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%.…
More Releases for ESRD
Driving End Stage Renal Disease (ESRD) Drug Market Growth in 2025: The Role of T …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
End Stage Renal Disease (ESRD) Drug Market Size Growth Forecast: What to Expect by 2025?
The market size for drugs treating end stage renal disease (ESRD) has seen a quick expansion in the recent past. The market, which was valued at $131.41 billion in 2024, is forecasted to reach $149.88 billion in 2025, displaying…
End Stage Renal Disease (ESRD) Drug Industry Report 2025-2034: Market Dynamics, …
The End Stage Renal Disease (ESRD) Drug Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current End Stage Renal Disease (ESRD) Drug Market Size and Its Estimated Growth Rate?
The market size for end-stage renal disease (ESRD) medications has witnessed a rapid upsurge…
End Stage Renal Disease (ESRD) Drug Market Report 2024 - End Stage Renal Disease …
"The Business Research Company recently released a comprehensive report on the Global End Stage Renal Disease (ESRD) Drug Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The…
End-Stage Renal Disease (ESRD) Market Share, Revenue, Prospects and Forecast 202 …
In recent years, the global End-Stage Renal Disease (ESRD) Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on End-Stage Renal Disease (ESRD) Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business…
End Stage Renal Disease (ESRD) Drug Market Size, Share, and Scope 2033
The new report published by The Business Research Company, titled ""End Stage Renal Disease (ESRD) Drug Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the end stage renal disease (esrd) drug market size has grown rapidly in recent years.…
End Stage Renal Disease (ESRD) Drug Market 2024-2033: Trends, Analysis & Growth …
The end stage renal disease (esrd) drug market size has grown rapidly in recent years. It will grow from $116.32 billion in 2023 to $132.86 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to increasing incidence of end stage renal disease, growing aging population, improved access to healthcare services, government initiatives and policies, increasing adoption…
